Hikma Pharmaceuticals PLC (Hikma), the multinational pharmaceutical company, today announces the launch of the first-of-its-kind, ready-to-use vancomycin premix with room-temperature stability under ...
Cevostamab demonstrated a 38.8% overall response rate in relapsed/refractory multiple myeloma, with a median response duration of 12.3 months. BCMA-naive patients showed a higher overall response rate ...
GC Biopharma (006280.KS), a leading global biopharmaceutical company, today announced the first shipment of BARYTHRAX inj., ...
The nonprofit operating the controversial facilities doesn't track outcomes for patients experiencing cardiac arrest, strokes ...
Intravenous iron shows safe and beneficial outcomes for patients with bacterial infection and anemia
Treatment with intravenous (IV) iron significantly improved survival and increased hemoglobin levels in patients with ...
New York City’s two government-funded shooting galleries are supposed to prevent fatal overdoses — but at least 46 clients ...
The Chosun Ilbo on MSN
Park Na-rae's 'Injection Auntie' defends against medical claims
Comedian Park Na-rae, 40 years old, has faced allegations of receiving illegal medical treatments, following prior ...
The Chosun Ilbo on MSN
Park Na-rae scrutinized in 'Injection Auntie' medical controversy
Comedian Park Na-rae, who has faced allegations of power abuse against her manager and embezzlement suspicions, is now under scrutiny for allegedly receiving unauthorized medical treatment. The ...
Piperacillin and Tazobactam in the DUPLEX Drug Delivery System is one of many planned injectable drugs B. Braun will launch in the U.S. in the next several years to expand its portfolio and help meet ...
Sapu Nano today announced new pharmacokinetic (PK) and tissue-distribution results demonstrating that Sapu003, the company's intravenous (IV) Deciparticle(TM) formulation of everolimus, substantially ...
Oncotelic Therapeutics, Inc. (OTCQB: OTLC) 45% owned Joint Venture, Sapu Nano today announced new pharmacokinetic (PK) and tissue-distribution results demonstrating that Sapu003, the company’s ...
ANI’s FutureVision Advisory Council is co-led by Arshad M. Khanani, MD, MA, FASRS, who serves as Principal Retina Advisor and Chair, and Peter Chang, MD, FACS who serves as Principal Uveitis Advisor ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results